Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1304950

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1304950

Automated Insulin Delivery System Market by Disease Type, Distribution - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

PUBLISHED:
PAGES: 187 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Online Access - 1 Year (Single User License)
USD 3949
PDF, Excel & Online Access - 1 Year (Single User License)
USD 4949
PDF, Excel & Online Access - 1 Year (Up to 5 User License)
USD 5949
PDF, Excel & Online Access - 1 Year (Site License)
USD 6949
PDF, Excel & Online Access - 1 Year (Enterprise User License)
USD 8949

Add to Cart

The Global Automated Insulin Delivery System Market is forecasted to grow significantly, with a projected USD 821.39 million in 2023 at a CAGR of 9.77% and expected to reach a staggering USD 1,579.49 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Automated Insulin Delivery System Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Automated Insulin Delivery System Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Disease Type, market is studied across Type I Diabetes and Type II Diabetes. The Type I Diabetes is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across Diabetes Clinics, Hospital Pharmacies, and Retail Pharmacies. The Diabetes Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Automated Insulin Delivery System Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Automated Insulin Delivery System Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Automated Insulin Delivery System Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Automated Insulin Delivery System Market?

4. What is the competitive strategic window for opportunities in the Global Automated Insulin Delivery System Market?

5. What are the technology trends and regulatory frameworks in the Global Automated Insulin Delivery System Market?

6. What is the market share of the leading vendors in the Global Automated Insulin Delivery System Market?

7. What modes and strategic moves are considered suitable for entering the Global Automated Insulin Delivery System Market?

Product Code: MRR-437517DB6E87

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Automated Insulin Delivery System Market, by Disease Type, 2022 vs 2030
  • 4.3. Automated Insulin Delivery System Market, by Distribution, 2022 vs 2030
  • 4.4. Automated Insulin Delivery System Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of diabetes coupled with increasing number of awareness campaigns
      • 5.1.1.2. Availability of improved pipelined and marketed AID systems
      • 5.1.1.3. Developments in AID systems with improved clinical outcomes
    • 5.1.2. Restraints
      • 5.1.2.1. Calibration of a glucose sensor, sensor durability, skin-related issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Up-gradation of existing insulin pumps and new product developmen
      • 5.1.3.2. Increasing R&D activities for the production of innovative insulin delivery systems
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding pump imprecision and sensor inaccuracy or unreliability
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization
    • 5.9.1. Pricing Analysis & Trend
    • 5.9.2. Supply Chain Analysis

6. Automated Insulin Delivery System Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Type I Diabetes
  • 6.3. Type II Diabetes

7. Automated Insulin Delivery System Market, by Distribution

  • 7.1. Introduction
  • 7.2. Diabetes Clinics
  • 7.3. Hospital Pharmacies
  • 7.4. Retail Pharmacies

8. Americas Automated Insulin Delivery System Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Automated Insulin Delivery System Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Automated Insulin Delivery System Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
Product Code: MRR-437517DB6E87

LIST OF FIGURES

  • FIGURE 1. AUTOMATED INSULIN DELIVERY SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2022 VS 2030
  • FIGURE 3. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2022 VS 2030 (%)
  • FIGURE 5. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
  • FIGURE 6. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. AUTOMATED INSULIN DELIVERY SYSTEM MARKET DYNAMICS
  • FIGURE 8. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AUTOMATED INSULIN DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE I DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE II DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 8. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. AUTOMATED INSULIN DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 98. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 99. AUTOMATED INSULIN DELIVERY SYSTEM MARKET LICENSE & PRICING
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!